The largest database of trusted experimental protocols

Matrigel coated plate

Manufactured by BD
Sourced in United States, France

Matrigel-coated plates are a type of cell culture substrate used in laboratory settings. Matrigel is a gelatinous protein mixture extracted from Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells, which provides a basement membrane-like environment for cell growth and differentiation. These plates are pre-coated with Matrigel, allowing cells to be cultured in a more physiologically relevant matrix.

Automatically generated - may contain errors

74 protocols using matrigel coated plate

1

Cell Culture and Differentiation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 (ATCC CRL-1573) and NCCIT (ATCC CRL-2073) cells were cultured in high-glucose DMEM supplemented with 10% FCS and 2 mM glutamine. For differentiation assays, NCCIT cells were cultured in the presence of 10 µM retinoic acid (Sigma-Aldrich) or 2 µM SB431542 (Sigma-Aldrich) and the medium was changed daily over a period of one week. hESC line H1 were grown on BD Matrigel-coated plates in mouse embryonic fibroblast (MEF)-conditioned medium containing 8 ng/ml bFGF (Preprotech).
+ Open protocol
+ Expand
2

Huntington's Disease hiPSC Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two human iPSC lines were employed in this study. Firstly, the CS83iCTR-33nXX (CTR33) line was used, which was derived from an unaffected sibling of a HD patient with genotyped CAG repeat length of 33 in the HTT gene. This line was reprogrammed using a non-integrating strategy and was developed as a “control” line for a related study on HD hiPSC characterization (Telezhkin et al., 2018 (link)). Secondly, the CS21iHD60n5 (HD60) line was used (Hd iPSC Consortium, 2017 (link)) which was derived from an HD juvenile patient and re-programmed using integrating vectors.
HiPSC lines were cultured and differentiated as previously described (Comella-Bolla et al., 2020 (link)). In brief, cells were kept in the pluripotent state using mTeSRTM1 (Stem Cell Technologies, Grenoble, France) on BD Matrigel-coated plates (BD Biosciences, Oxford, Oxon, United Kingdom), and differentiated to neural progenitors using an in-house differentiation protocol as described elsewhere (Comella-Bolla et al., 2020 (link)).
+ Open protocol
+ Expand
3

Inducing Cardiomyocyte Differentiation from KS iPS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce the KS iPS cells to differentiate into cardiomyocyte‐like cells, we used PSdif‐CardioR (StemRD). Briefly, KS iPS cells were cultured under feeder‐free conditions on thin layer Matrigel‐coated plates (BD Biosciences). The cells were incubated successively in PSdif‐CardioR A, B, and C media (according to the manufacturer's instructions) to induce cardiogenesis. Clusters of beating cells typically appeared approximately 14 days after induction.
+ Open protocol
+ Expand
4

Healthy Control Donor hiPSC Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The generation of hiPSCs from a healthy control donor was performed as previously described [40 ]. Peripheral blood mononuclear cells from healthy control donor were collected for iPSC induction. Cells were transduced with the integration-free CytoTune-iPS Sendai Reprogramming Kit (Life Technologies, Carlsbad, CA, USA), which utilizes Sendai virus particles of the four factors (OCT4, SOX2, c-MYC, and KLF4). Transduced cells were plated on vitronectin-coated culture dishes and fed iPSC medium, which was replaced by StemPro 34 SFM (Life Technologies) from days 3 to 7. On day 7, the medium was replaced by feeder-free mTeSR1medium (STEMCELL Technologies, Vancouver, BC, Canada) until small colonies were formed. The growth of small colonies was maintained for another 3–4 weeks, and cell colonies were manually picked and mechanically dissociated for the first four passages. The hiPSCs were maintained on Matrigel-coated plates (BD Bioscience, Franklin Lakes, NJ, USA) with mTeSR1 medium (STEMCELL Technologies), and passaged every 4–5 days using 1 mg/mL dispase (Life Technologies). All experimental protocols including human stem cell use were approved by the Ethics Committee at the First Affiliated Hospital of Sun Yat-sen University.
+ Open protocol
+ Expand
5

Quantifying EPC Tube Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum-starved EPCs were seeded onto Matrigel-coated plates (BD Biosciences, USA) in EBM medium and incubated at 37°C for 24 h, and tubular structures of EPCs in the Matrigel were analyzed by phase-contrast microscopy. To quantify the length of newly formed tubes, 6 random phase-contrast photomicrographs per well were taken and the length of each tube was measured using Quantity One Image software.
+ Open protocol
+ Expand
6

Stepwise hESC Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
hESC (WA01/H1 line; WiCell) were cultured on Matrigel-coated plates (BD Biosciences) in Essential 8 medium (A1517001; Life Technologies). Differentiation was carried out following a seven-stage protocol as previously described (21 (link)–23 (link)) with further modifications. The glucose concentration of each stage was as follows: S1–S4 cells were cultured in 10.5 mmol/L glucose; S5–S6 cells were cultured in 20.5 mmol/L glucose; and S7 cells were cultured in 5.5 mmol/L glucose.
+ Open protocol
+ Expand
7

Directed Differentiation of hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic stem cells (hESC) (WA01/H1 line, Wicell) were cultured on Matrigel-coated plates (BD Biosciences) in Essential 8 (E8) medium (Life technologies, A1517001). Differentiation was carried out following a seven-stage protocol as previously described with further modifications (21 (link)–23 ). The glucose concentration of each stage was as follow: S1-S4 cells were cultured in 10.5 mM glucose; S5-S6 cells were cultured in 20.5 mM glucose; and S7 cells were cultured in 5.5 mM glucose.
+ Open protocol
+ Expand
8

Generating Human iPSC-Derived Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
All of the protocols for this study were approved by the Stanford University Human Subjects Research Institutional Review Board (IRB). Human iPSC lines were maintained on Matrigel-coated plates (BD Biosciences, San Jose, CA) in Essential 8™ Medium (Gibco®, Life Technology). Human iPSC-CMs were generated as described previously (Lian et al., 2012 (link)). Briefly, pluripotent stem cells were treated with 6 μM CHIR99021 (Selleckchem.com) for 2 days, recovered in insulin-minus RPMI+B27 for 24 hr, treated with 5 μM IWR-1 (Sigma) for 2 days, and then insulin minus medium for another 2 days, and finally switched to RPMI+B27 plus insulin medium. Beating cells were observed at day 9-11 after differentiation. iPSC-CMs were re-plated and purified with glucose-free medium treatment for 2-3 rounds. Typically, cultures were more than 90% pure by FACS assessment of TNNT2+ cells after purification. Cultures were maintained in a 5% CO2/air environment.
+ Open protocol
+ Expand
9

Directed Differentiation of Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A schematic representation of differentiation protocol is presented in Figure 1A. In brief, hESC and hiPSC were seeded at 1.7 × 104 cells per square centimeter 30 on BD Matrigel‐coated plates and kept in mTeSR1 medium for two days. Rho kinase inhibitor, Y27632 (Chemdea, NJ, USA) [10 µM) was added to the mTeSR1 medium for the first 24 hours. Eight differentiation induction media listed in Figure 1B were introduced to the cells according to the respective groups on day 3 and maintained until day 9. The cells were then replated at 1.7 × 104 cells per square centimeter onto 0.05 mg/ml collagen‐IV–coated plates 22 on day 9 and supplemented with CnT‐Prime medium (CELLnTEC, Switzerland) and 10% serum for the next 11 days. Three technical and three biological repeats were set up for each differentiation group.
+ Open protocol
+ Expand
10

Cardiomyocyte Differentiation from hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The preparation of hiPSCs is illustrated in Figure 1A. The hiPSCs from reprogrammed fibroblasts (GM23338, Coriell Institute for Medical Research, NJ, USA) were delivered and stored in liquid nitrogen until use. After defrosting, cells were cultured according to a previously described protocol23 (link). Briefly, hiPSC cells were cultured on Matrigel-coated plates (BD Biosciences) with stem basal medium (mTeSR1, STEMCELL Technologies) for about 5 days to reach 80–90% of confluence. On day 0, hiPSCs were treated with 12 μM CHIR99021 (Tocris, 4423) diluted in RPMI/B27 minus insulin for 24 hours. On day 3, hiPSCs were treated with 5 μM IWP4 (Tocris, 5214) mixed with RPMI/B27 minus insulin, removed on day 4. The medium was changed every other day. From day 8, hiPSCs were maintained in RPMI/B27 containing insulin with regular medium change. Spontaneous contractions were observed between days 8 and 10. Following the previously reported protocol24 (link), to increase the percentage of CMs, on the first day of beating, the hiPSCs were treated with the Lactate medium, with 5mM L-Lactate (Sigma, 71718) diluted in RPMI without glucose (Gibco, 11879–020), for 3 days. The medium was replaced daily.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!